These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36868900)

  • 1. Effects of transjugular intrahepatic portosystemic shunt on abdominal muscle mass in patients with decompensated cirrhosis.
    Wu CH; Ho MC; Kao JH; Ho CM; Su TH; Hsu SJ; Huang HY; Lin CY; Liang PC
    J Formos Med Assoc; 2023 Aug; 122(8):747-756. PubMed ID: 36868900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fat-free muscle mass in magnetic resonance imaging predicts acute-on-chronic liver failure and survival in decompensated cirrhosis.
    Praktiknjo M; Book M; Luetkens J; Pohlmann A; Meyer C; Thomas D; Jansen C; Feist A; Chang J; Grimm J; Lehmann J; Strassburg CP; Abraldes JG; Kukuk G; Trebicka J
    Hepatology; 2018 Mar; 67(3):1014-1026. PubMed ID: 29059469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sarcopenia in Patients with Cirrhosis after Transjugular Intrahepatic Portosystemic Shunt Placement.
    Liu J; Ma J; Yang C; Chen M; Shi Q; Zhou C; Huang S; Chen Y; Wang Y; Li T; Xiong B
    Radiology; 2022 Jun; 303(3):711-719. PubMed ID: 35289658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sarcopenia is an independent risk factor for short-term mortality in patients undergoing transjugular intrahepatic portosystemic shunt.
    Stoffel E; Hwang SY; Qian X; Geller B; Morelli G; Zhang W
    Eur J Gastroenterol Hepatol; 2024 Aug; 36(8):1010-1015. PubMed ID: 38808872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sarcopenia Is Associated With Development of Acute-on-Chronic Liver Failure in Decompensated Liver Cirrhosis Receiving Transjugular Intrahepatic Portosystemic Shunt.
    Praktiknjo M; Clees C; Pigliacelli A; Fischer S; Jansen C; Lehmann J; Pohlmann A; Lattanzi B; Krabbe VK; Strassburg CP; Arroyo V; Merli M; Meyer C; Trebicka J
    Clin Transl Gastroenterol; 2019 Apr; 10(4):e00025. PubMed ID: 30939488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contributory roles of sarcopenia and myosteatosis in development of overt hepatic encephalopathy and mortality after transjugular intrahepatic portosystemic shunt.
    Yin L; Chu SL; Lv WF; Zhou CZ; Liu KC; Zhu YJ; Zhang WY; Wang CX; Zhang YH; Lu D; Cheng DL
    World J Gastroenterol; 2023 May; 29(18):2875-2887. PubMed ID: 37274064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nutritional status in hepatic encephalopathy and transjugular intrahepatic portosystemic shunt - TIPS, and strategies to improve the outcomes.
    Berenguer M
    Acta Gastroenterol Belg; 2023; 86(2):318-322. PubMed ID: 37428165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TIPS placement as the first-line therapy to prevent variceal rebleeding in patients with cirrhosis and sarcopenia.
    Xiong B; Yang C; Zhou C; Wu X; Huang S
    Eur J Radiol; 2023 Jan; 158():110630. PubMed ID: 36455336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of sarcopenia predicts survival after a transjugular intrahepatic portosystemic stent.
    Tsien C; Shah SN; McCullough AJ; Dasarathy S
    Eur J Gastroenterol Hepatol; 2013 Jan; 25(1):85-93. PubMed ID: 23011041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transjugular intrahepatic portosystemic shunt in decompensated cirrhotic patients in a tertiary hospital in southern Brazil.
    Titton CM; Torikachvili M; Rêgo HMC; Medronha EF; Ziemiecki Junior E; Ribas C; Ceratti CG; Mattos AA; Tovo CV
    Rev Assoc Med Bras (1992); 2023; 69(4):e20220944. PubMed ID: 37075438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increase of radiologically determined muscle area in patients with liver cirrhosis after transjugular intrahepatic portosystemic shunt.
    March C; Thormann M; Geipel S; Sowa JP; Barajas Ordonez F; Pech M; Omari J; Lemmer P
    Sci Rep; 2023 Oct; 13(1):17092. PubMed ID: 37816875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of nutritional status on the outcome of transjugular intrahepatic portosystemic shunt in patients with cirrhosis: a systematic review.
    Giri S; Anirvan P; Chaudhary M; Tripathy T; Patel RK; Rath MM; Panigrahi MK
    Br J Radiol; 2024 Feb; 97(1154):331-340. PubMed ID: 38276881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Transjugular intrahepatic portosystemic shunt for esophagogastric variceal bleeding in liver cirrhosis: intended population and timing].
    Lyu Y; Han GH; Fan DM
    Zhonghua Gan Zang Bing Za Zhi; 2017 Jun; 25(6):402-407. PubMed ID: 28763854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigating the risk factors of hepatocellular carcinoma and survival analysis for cirrhosis after transjugular intrahepatic portosystemic shunt in treating portal hypertension.
    Wei J; Li H; Li C
    J Cancer Res Ther; 2018; 14(4):826-832. PubMed ID: 29970660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of portosystemic gradient during transjugular intrahepatic portosystemic shunt achieves good outcome and reduces complications.
    Luo SH; Zhou MM; Cai MJ; Han SL; Zhang XQ; Chu JG
    World J Gastroenterol; 2023 Apr; 29(15):2336-2348. PubMed ID: 37124886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transjugular intrahepatic portosystemic shunt in cirrhosis: An exhaustive critical update.
    Rajesh S; George T; Philips CA; Ahamed R; Kumbar S; Mohan N; Mohanan M; Augustine P
    World J Gastroenterol; 2020 Oct; 26(37):5561-5596. PubMed ID: 33088154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscle Gain after Transjugular Intrahepatic Portosystemic Shunt Creation: Time Course and Prognostic Implications for Survival in Cirrhosis.
    Jahangiri Y; Pathak P; Tomozawa Y; Li L; Schlansky BL; Farsad K
    J Vasc Interv Radiol; 2019 Jun; 30(6):866-872.e4. PubMed ID: 31053265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sarcopenia Defined by Psoas Muscle Thickness Predicts Mortality After Transjugular Intrahepatic Portosystemic Shunt.
    Li T; Liu J; Zhao J; Bai Y; Huang S; Yang C; Wang Y; Zhou C; Wang C; Ju S; Chen Y; Yao W; Xiong B
    Dig Dis Sci; 2023 Apr; 68(4):1641-1652. PubMed ID: 36583804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical portosystemic shunts versus transjugular intrahepatic portosystemic shunt for variceal haemorrhage in people with cirrhosis.
    Brand M; Prodehl L; Ede CJ
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD001023. PubMed ID: 30378107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early transjugular intrahepatic portosystemic shunt in US patients hospitalized with acute esophageal variceal bleeding.
    Njei B; McCarty TR; Laine L
    J Gastroenterol Hepatol; 2017 Apr; 32(4):852-858. PubMed ID: 27624167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.